Webinar: Implantation the medical point of view: The place of Immunology

AREA: Gynecology, Reproduction

LANGUAGE: English

SEATS: 150

STUDENTS: 150/150 (100%)

HOURS: 1 theoretical

DATES: 20/05/2020

MODALITY: Online

SPEAKER: Diana Alecsandru

Dates

20/05/2020

Schedule

17:00 GMT+2

Location

IVI Global Education Webinar Platform

Enrollment

Free

Speaker:

Diana Alecsandru MD, PH. D.

Physician for Reproductive Immunology at IVI Madrid

Intended to

Specialists in Biomedical Sciences, Biotechnologists, Embryologists and Gynecological Doctors specialized in Reproductive Medicine

Description

Chromosome screening and egg donation significantly increases pregnancy and delivery rates, but still not 100% of euploid embryos implant.

Other factors, not just embryo aneuploidies, might contribute to implantation failure or miscarriage, such as an imbalance in the immune maternal tolerance to pregnancy. The role of the immune system in recurrent miscarriage (RM) and recurrent implantation failure (RIF) is less known. Maternal tolerance begins at the uterine level, and successful adaptation to the semiallogeneic fetus is a complicated process. Placentation is regulated by interactions between maternal immune cells and fetal molecules, expressed by extravillous trophoblast (EVT) cells.

The maternal immune system is one of the main actors at the maternal –fetal interface, and its dysregulation as lack of activation or an overreactivity seems to influence placentation and pregnancy outcomes. 

Finished course

Do you want more information?

I give my consent for:

IVI Foundation to send me commercial communications.

IVI Foundation can share my data with other IVI Group companies if strictly necessary.

Send